SEC 13F Intelligence

Managers / Q2 2022 · view latest →

TradeLink Capital LLC

CIK 0001642044 · 71 S. WACKER DR., SUITE 1900, CHICAGO, IL, 60606 · 312-264-2196

Reported Value
$4M
Q2 2022
Positions
1
Filings on Record
32
2019–present window
Filed
Aug 9, 2022
original filing

Summary

Tradelink Capital LLC reported $4M in U.S.-listed holdings across 1 positions for Q2 2022.

The portfolio is heavily concentrated: XBI alone accounts for 100.0% of reported value.

Compared with Q1 2022, the fund opened 0 new positions and exited 17.

Portfolio Metrics

Turnover
+28.7%
vs prior filed quarter
Largest Position
+100.0%
Spdr S P Biotech Etf

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $3MQ4 ’18Q1 ’19: $19MQ2 ’19: $7MQ3 ’19: $14MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $24MQ3 ’20: $5MQ4 ’20: $314,000Q4 ’20Q1 ’21: $7MQ2 ’21: $4MQ3 ’21: $12MQ4 ’21: $527,000Q4 ’21Q1 ’22: $22MQ2 ’22: $4MQ3 ’22: $5MQ4 ’22: $4,642Q4 ’22Q2 ’23: $3MQ3 ’23: $3,227Q4 ’23: $7MQ1 ’24: $7MQ1 ’24Q2 ’24: $35MQ1 ’25: $16MQ2 ’25: $28MQ3 ’25: $14MQ3 ’25Q4 ’25: $13MQ1 ’26: $13Mfilingsflow.com

Portfolio Composition

By security type
ETP: 100.0%
  • ETP · 100.0% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
XBISPDR S&P Biotech ETFADDED+52.0K60.0K+$4M$4M
LINDE PLCSOLD OUT−15.8K0−$5M$0
SMHVANECK VECTORS ETF TRSOLD OUT−7.8K0−$2M$0
ABNBAIRBNB INCSOLD OUT−11.0K0−$2M$0
MARATHON OIL CORPSOLD OUT−62.2K0−$2M$0
AAALCOA CORPSOLD OUT−15.0K0−$1M$0
TRGPTARGA RES CORPSOLD OUT−17.4K0−$1M$0
CLFCLEVELAND-CLIFFS INC NEWSOLD OUT−38.0K0−$1M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

1 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P Biotech ETFhistory →COM100.00%$4M60.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$13M34May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$13M27Feb 4, 202613F-HRchanges · EDGAR ↗
Q3 2025$14M31Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$28M51Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M40May 8, 202513F-HRchanges · EDGAR ↗
Q4 2024Under review26Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024Under review1Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$35M88Aug 8, 202413F-HRchanges · EDGAR ↗
Q1 2024$7M21May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$7M19Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$3,2272Nov 9, 202313F-HRchanges · EDGAR ↗
Q2 2023$3M10Aug 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$4,6422Feb 13, 2023RESTATEMENTchanges · EDGAR ↗
Q3 2022$5M4Nov 8, 202213F-HRchanges · EDGAR ↗
Q2 2022$4M1Aug 9, 202213F-HRchanges · EDGAR ↗
Q1 2022REVEALED$22M32May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$527,0002Jan 27, 202213F-HRchanges · EDGAR ↗
Q3 2021$12M4Oct 29, 202113F-HRchanges · EDGAR ↗
Q2 2021$4M1Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$7M15May 7, 202113F-HRchanges · EDGAR ↗
Q4 2020$314,0002Feb 1, 202113F-HRchanges · EDGAR ↗
Q3 2020$5M5Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$24M53Jul 29, 202013F-HRchanges · EDGAR ↗
Q1 2020$3M2May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$3M6Feb 10, 202013F-HRchanges · EDGAR ↗
Q3 2019$14M24Oct 28, 201913F-HRchanges · EDGAR ↗
Q2 2019$7M10Jul 31, 201913F-HRchanges · EDGAR ↗
Q1 2019$19M33Apr 25, 201913F-HRchanges · EDGAR ↗
Q4 2018$3M2Feb 8, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.